These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Coronavirus Porcine Epidemic Diarrhea Virus Nucleocapsid Protein Interacts with p53 To Induce Cell Cycle Arrest in S-Phase and Promotes Viral Replication. Su M; Shi D; Xing X; Qi S; Yang D; Zhang J; Han Y; Zhu Q; Sun H; Wang X; Wu H; Wang M; Wei S; Li C; Guo D; Feng L; Sun D J Virol; 2021 Jul; 95(16):e0018721. PubMed ID: 34037422 [TBL] [Abstract][Full Text] [Related]
6. The SKI complex is a broad-spectrum, host-directed antiviral drug target for coronaviruses, influenza, and filoviruses. Weston S; Baracco L; Keller C; Matthews K; McGrath ME; Logue J; Liang J; Dyall J; Holbrook MR; Hensley LE; Jahrling PB; Yu W; MacKerell AD; Frieman MB Proc Natl Acad Sci U S A; 2020 Dec; 117(48):30687-30698. PubMed ID: 33184176 [TBL] [Abstract][Full Text] [Related]
7. Targeting Innate Immunity for Antiviral Therapy through Small Molecule Agonists of the RLR Pathway. Pattabhi S; Wilkins CR; Dong R; Knoll ML; Posakony J; Kaiser S; Mire CE; Wang ML; Ireton RC; Geisbert TW; Bedard KM; Iadonato SP; Loo YM; Gale M J Virol; 2015 Dec; 90(5):2372-87. PubMed ID: 26676770 [TBL] [Abstract][Full Text] [Related]
8. Identification of an Antiretroviral Small Molecule That Appears To Be a Host-Targeting Inhibitor of HIV-1 Assembly. Reed JC; Solas D; Kitaygorodskyy A; Freeman B; Ressler DTB; Phuong DJ; Swain JV; Matlack K; Hurt CR; Lingappa VR; Lingappa JR J Virol; 2021 Jan; 95(3):. PubMed ID: 33148797 [TBL] [Abstract][Full Text] [Related]
9. Dual myxovirus screen identifies a small-molecule agonist of the host antiviral response. Yan D; Krumm SA; Sun A; Steinhauer DA; Luo M; Moore ML; Plemper RK J Virol; 2013 Oct; 87(20):11076-87. PubMed ID: 23926334 [TBL] [Abstract][Full Text] [Related]
10. Identification of common biological pathways and drug targets across multiple respiratory viruses based on human host gene expression analysis. Smith SB; Dampier W; Tozeren A; Brown JR; Magid-Slav M PLoS One; 2012; 7(3):e33174. PubMed ID: 22432004 [TBL] [Abstract][Full Text] [Related]
11. Viral capsid assembly as a model for protein aggregation diseases: Active processes catalyzed by cellular assembly machines comprising novel drug targets. Marreiros R; Müller-Schiffmann A; Bader V; Selvarajah S; Dey D; Lingappa VR; Korth C Virus Res; 2015 Sep; 207():155-64. PubMed ID: 25451064 [TBL] [Abstract][Full Text] [Related]
12. Highly Potent Host-Specific Small-Molecule Inhibitor of Paramyxovirus and Pneumovirus Replication with High Resistance Barrier. Shrestha N; Gall FM; Mathieu C; Hierweger MM; Brügger M; Alves MP; Vesin J; Banfi D; Kalbermatter D; Horvat B; Chambon M; Turcatti G; Fotiadis D; Riedl R; Plattet P mBio; 2021 Dec; 12(6):e0262121. PubMed ID: 34724816 [TBL] [Abstract][Full Text] [Related]
13. Preclinical Characterization of NVR 3-778, a First-in-Class Capsid Assembly Modulator against Hepatitis B Virus. Lam AM; Espiritu C; Vogel R; Ren S; Lau V; Kelly M; Kuduk SD; Hartman GD; Flores OA; Klumpp K Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30373799 [TBL] [Abstract][Full Text] [Related]
16. A Novel Agonist of the TRIF Pathway Induces a Cellular State Refractory to Replication of Zika, Chikungunya, and Dengue Viruses. Pryke KM; Abraham J; Sali TM; Gall BJ; Archer I; Liu A; Bambina S; Baird J; Gough M; Chakhtoura M; Haddad EK; Kirby IT; Nilsen A; Streblow DN; Hirsch AJ; Smith JL; DeFilippis VR mBio; 2017 May; 8(3):. PubMed ID: 28465426 [TBL] [Abstract][Full Text] [Related]